EMC2 Awards/2019 - The Einsteinium Foundation Awards page is live! Check it out at: https://www.emc2.foundation/einsteinium-awards/
The Einsteinium Foundation invites projects for consideration for second annual award with the winner to be announced in late 2019. We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.
Contact projects@emc2.foundation for more information.
January 2019 - The Einsteinium Foundation (EMC2) is proud to announce the finalists for the first annual Einsteinium Awards. This year's winners are:
Minh Thang “Harry” Hoang - McGill University
Michael Sayre - Global Cell Med
The Einsteinium Awards celebrates innovative work across all areas of science. We aim to engage and foster a community devoted to scientific research as a long-term investment in our future and future of our planet.
The award is 100,000 EMC2 coins, which will be evenly split amongst our two winners. The EMC2 awards is funded directly by the EMC2 Foundation.
Dr. Thang Hoang has widely published, including six first author papers, his work as a PhD candidate in Electrical Engineering under Professor David V. Plant’s supervision in the Photonic Systems Group at McGill University. His cutting-edge work on a novel and effective self-coherent transceiver using Stokes Vector modulation may impact global information traffic and allow for faster data connections.
Michael Sayre is the CEO of Global Cell Med, a biotech company specializing in a regenerative medicine approach to treating diabetes. The company has published its therapeutic strategy and is currently conducting clinical trials on patients with chronic Type 1 Diabetes, with very promising early results.
Our first annual award attracted a global pool of applicants with equally diverse backgrounds. This included an applicant in the social sciences from Georgia State University and a stem cell biologist from the First Moscow State Medical University.
The inaugural class has set an amazing example on what community based and open science can be. We look forward to our applicant pool next year. Interested parties should contact: projects@emc2.foundation to find out more.
Despite the need for research and development to spur innovative solutions for a host of urgent problems. Unfortunately, in most countries, public commitments for scientific research have continued to fall. However, the Einsteinium Foundation hopes to play a part in reversing that trend. Blockchain based funding for scientific research is an innovative means to accomplish that end. We are only at the beginning to see what this new type of funding will mean for science.
Press contact: Alexander Lucaci, Alexander.Lucaci@emc2.foundation
About the Einsteinium Foundation:
The Einsteinium Foundation is an official Non-Profit Organization (NPO), and the world's first NPO to be backed by cryptocurrency. The defining characteristics of the Einsteinium Foundation are its ongoing commitment to research and charitable missions throughout the world, and to the safeguarding, maintenance, and development of Einsteinium, an international digital currency built on a secure, decentralized open ledger, or blockchain.
EMC2 Awards/2018 - The Einsteinium Foundation Awards page is live! Check it out at: https://www.emc2.foundation/einsteinium-awards/
The Einsteinium Foundation invites projects for consideration for our annual award with the winner to be announced in mid-September 2018. We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.
Contact projects@emc2.foundation for more information.
EMC2 Awards/2018 - in California. Submit your work now. The Einsteinium Foundation invites projects for consideration for our annual award with the winner to be announced in mid-September 2018. Interested? Contact projects@emc2.foundation for more information.
We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.
Global Cell Med (GCM) is not a household name, but someday that could change. The organization, based out of the Bahamas, under the direction of Dr. Alejandro Mesples has been working on a procedure to treat Diabetes Type One, a global epidemic currently affecting more than 30 million adults and children in the US alone.
Scientists and science allies are gathering today (April 22) in Washington, D.C., and in more than 600 cities around the world, for the 2017 March for Science. Marchers are voicing support for scientists and safeguards to the scientific community.
Find out more on www.marchforscience.com
